Enhanced therapy for coronary artery disease and diabetes mellitus: impact on biomarkers and clinical outcomes
Background. Cardiovascular diseases like coronary artery disease (CAD) are a major global health issue, causing millions of deaths each year. Type 2 diabetes mellitus (T2DM) worsens outcomes for those with CAD. Common risk factors suggest potential synergistic treatment approaches, including the use...
Saved in:
| Main Authors: | S.V. Fedorov, O.M. Didushko, N.B. Nyshchuk-Oliinyk, N.Z. Pozur, M.V. Bielinskyi, A.S. Herashchenko |
|---|---|
| Format: | Article |
| Language: | English |
| Published: |
Zaslavsky O.Yu.
2024-05-01
|
| Series: | Mìžnarodnij Endokrinologìčnij Žurnal |
| Subjects: | |
| Online Access: | https://iej.zaslavsky.com.ua/index.php/journal/article/view/1385 |
| Tags: |
Add Tag
No Tags, Be the first to tag this record!
|
Similar Items
-
Improvement of the efficiency of treatment in patients with coronary artery disease and metabolic syndrome after percutaneous coronary intervention for acute coronary syndrome without ST-segment elevation.
by: N. V. Chumachenko
Published: (2016-05-01) -
The combined effects of ursodesoxycholic acid and quercetin on liver health and cardiac function in patients with non-alcoholic fatty liver disease and atrial fibrillation
by: O. B. Teslenko, et al.
Published: (2024-08-01) -
Features of metabolic correction in patients after percutaneous coronary intervention for acute coronary syndrome without ST elevation
by: L.S. Kholopov, et al.
Published: (2016-03-01) -
Evaluating the effects of empagliflozin in preventing myocardial injury in patients undergoing percutaneous coronary intervention: A double-blind, randomized clinical trial
by: Hossein Behzad, et al.
Published: (2024-06-01) -
DECLARE-TIMI 58 trial in the context of EMPA-REG OUTCOME and CANVAS
by: Marina V. Shestakova
Published: (2019-12-01)